RecruitingNCT07607938
Psilocybin for lasting loss of interest or pleasure in depression
About this title
Read the official source — NCT07607938Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
You receive a single dose of psilocybin or placebo (an inactive comparison treatment) while continuing your SSRI/SNRI antidepressant. The registry lists six MRI (magnetic resonance imaging) sessions: two before the administration day and four after it.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Number of visits
- The registry lists 6 MRI (magnetic resonance imaging) sessions, with one study administration day.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 90
- Sponsor
- NYU Langone Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07607938
- Official title
Show the full official title
Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is NYU Langone Health.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
